Paul Segal - 15 Jun 2023 Form 4/A Insider Report for Alphatec Holdings, Inc. (ATEC)

Reporting relationship: Director
Issuer ticker: ATEC
Reported as of: 15 Jun 2023
Net transaction value: -$1,615,000
SEC form: 4/A
Accepted by SEC: 06 Mar 2024, 17:59:01 UTC
Original report date: 16 Jun 2023
Prior SEC filing: 14 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Paul Segal

Key filing fact

Paul Segal filed Form 4/A for Alphatec Holdings, Inc. (ATEC) on 06 Mar 2024.

Key facts

This page summarizes Paul Segal's Form 4/A filing for Alphatec Holdings, Inc. (ATEC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Mar 2024, 17:59.

Change

Previous filing in this sequence was filed on 14 Jun 2023.
Current net transaction value: -$1,615,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATEC transaction

Common Stock

Sale

Transaction value: $1,615,000
Shares: -100,000
Change %: -100%
Price: $16.15
Shares after: 0
Date: 15 Jun 2023
Ownership: Direct
Footnotes: F1

ATEC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,081,538
Date: 15 Jun 2023
Ownership: See footnote
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This amendment corrects the original Form 4 which was filed in error on June 16, 2023. The Form 4 was intended to disclose that (i) 100,000 shares were sold on June 15, 2023 at (ii) at a price per share of $16.15 and (iii) zero shares were beneficially owned following the transaction.

Footnote F2

Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.